Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Sep 25, 2023
Date Accepted: Dec 24, 2024

The final, peer-reviewed published version of this preprint can be found here:

User Experiences Among Patients and Health Care Professionals Who Participated in a Randomized Controlled Trial of E-nergEYEze, a Vision-Specific eHealth Intervention to Reduce Fatigue in Adults With Visual Impairment: Mixed Methods Study

Veldman M, van der Aa H, Knoop H, Bode C, van Rens G, van Nispen1 R

User Experiences Among Patients and Health Care Professionals Who Participated in a Randomized Controlled Trial of E-nergEYEze, a Vision-Specific eHealth Intervention to Reduce Fatigue in Adults With Visual Impairment: Mixed Methods Study

JMIR Form Res 2025;9:e53080

DOI: 10.2196/53080

PMID: 40773749

PMCID: 12371291

E-nergEYEze, a vision-specific E-health intervention to reduce fatigue in adults with visual impairment: user-experiences from patient s’ and healthcare professional s’ perspectives in a randomized controlled trial.

  • Manon Veldman; 
  • H.P.A. van der Aa; 
  • H. Knoop; 
  • C. Bode; 
  • G.H.M.B. van Rens; 
  • R.M.A. van Nispen1

ABSTRACT

Background:

E-nergEYEze, a blended vision-specific E-health intervention to reduce fatigue severity in adults with visual impairment, has been developed, pilot tested and studied in a randomized controlled trial (RCT).

Objective:

This study aimed to identify factors that drive participant behavior or affect outcomes. A process evaluation from the perspective of patients and professionals was considered relevant to complement (cost)-effectiveness outcomes.

Methods:

User-experiences of participants with visual impairment and severe fatigue (n=51), who were randomized to the intervention group of this RCT, and professionals (n=11) who provided blended support were evaluated. The Dutch Mental Health questionnaire and a therapist evaluation were used and analyzed using mixed methods. A focus group meeting was held for more in-depth information with involved social workers (n=4), computer trainer (n=1) and psychologists (n=2). The e-platform provided data on user-engagement.

Results:

The majority of patients were engaged, internalized personally relevant topics and made use of the benefits of E-health. Digital proficiency and having appropriate expectations were the most important factors for continuing the intervention. The effort made to reduce fatigue was perceived satisfying, however, some patients experienced the content as intense and challenging. Patients considered the frequency and quality of guidance highly relevant. In total, 87% of the patients would recommend others to engage in E-nergEYEze. Professionals reported that E-nergEYEze required patients’ self-efficacy, motivation and digital skills, therefore, pre-selection was essential. Professional affinity with E-health was considered essential to provide appropriate remote support.

Conclusions:

User-experiences underlined the potential of E-nergEYEze to reduce fatigue severity in adults with VI. E-health provides a treatment opportunity for target group in which guidance was considered as a highly relevant aspect. Attention to the training of professionals on providing remote support is essential. This process evaluation provided valuable insights to learn from and optimize E-nergEYEze to reduce fatigue in adults with VI. Clinical Trial: International Clinical Trial Registry Platform: NL77643. Date registered: 28-05-2019


 Citation

Please cite as:

Veldman M, van der Aa H, Knoop H, Bode C, van Rens G, van Nispen1 R

User Experiences Among Patients and Health Care Professionals Who Participated in a Randomized Controlled Trial of E-nergEYEze, a Vision-Specific eHealth Intervention to Reduce Fatigue in Adults With Visual Impairment: Mixed Methods Study

JMIR Form Res 2025;9:e53080

DOI: 10.2196/53080

PMID: 40773749

PMCID: 12371291

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.